Document Detail


Teicoplanin therapy in children: a review.
MedLine Citation:
PMID:  2151065     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Teicoplanin has been investigated mainly in adults and to a lesser extent in children. Pharmacological studies in children aged 2-12 years showed that a daily dose of 3-6 mg/kg of teicoplanin was insufficient to maintain microbiologically effective trough serum levels, while a regimen of 10 mg/kg/day was sufficient to obtain effective serum concentrations. Teicoplanin has been administered, alone or in combination therapy, to neutropenic or non-neutropenic paediatric patients. Combinations of teicoplanin (10 mg/kg/day) plus beta-lactams or aminoglycosides have been found effective in the treatment of febrile episodes in neutropenic (less than 500 pmn/microliters) children. Teicoplanin, 3-10 mg/kg i.v., has been administered as the sole antibiotic agent as a daily dose to more than 100 children and newborns with documented or suspected Gram-positive infections. Overall, teicoplanin was found to be a very effective and well tolerated treatment for Gram-positive infections in pediatric patients. Further trials are required to confirm these observations.
Authors:
D Bassetti; M Cruciani
Related Documents :
1298635 - Some characteristics of serum phenytoin concentration, in black zimbabwean volunteers.
7273665 - Thallium ingestion with survival: ineffectiveness of peritoneal dialysis and potassium ...
11434505 - The effect of genetic polymorphism of cytochrome p450 cyp2c9 on phenytoin dose requirem...
8176345 - The appropriateness of initial vancomycin dosing.
15569775 - Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-indu...
641635 - Glycine therapy in isovaleric acidemia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Scandinavian journal of infectious diseases. Supplementum     Volume:  72     ISSN:  0300-8878     ISO Abbreviation:  Scand J Infect Dis Suppl     Publication Date:  1990  
Date Detail:
Created Date:  1991-06-05     Completed Date:  1991-06-05     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0251025     Medline TA:  Scand J Infect Dis Suppl     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  35-7     Citation Subset:  IM    
Affiliation:
Institute of Infectious Diseases, University of Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bacterial Infections / drug therapy*
Child
Glycopeptides / pharmacokinetics,  therapeutic use
Humans
Neutropenia / complications*
Teicoplanin
Chemical
Reg. No./Substance:
0/Glycopeptides; 61036-62-2/Teicoplanin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics of teicoplanin in burn patients.
Next Document:  Spanish experience with teicoplanin.